Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dermatology

  Free Subscription


23.01.2023

11 Am J Dermatopathol
1 Am J Ophthalmol
2 Ann Intern Med
9 Br J Dermatol
3 Cancer
3 Cancer Res
13 Clin Exp Dermatol
7 Cutis
23 Int J Dermatol
2 J Cutan Pathol
3 J Dermatol
6 J Invest Dermatol
4 Lancet
2 N Engl J Med
1 PLoS Genet
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. CHIANG CT, Chuang SS, Lin HF, Li WH, et al
    Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype: Report of 2 Epstein-Barr Virus-Positive Cases.
    Am J Dermatopathol. 2023;45:73-80.
    PubMed         Abstract available

  2. ROVIRA-LOPEZ R, Gallardo F, Salar A, Colomo L, et al
    Epidermotropic B-Cell Lymphoma: A Case of Secondary Cutaneous Splenic Marginal Zone B-Cell Lymphoma With Autoinvolutive and Recurrent Cutaneous Lesions.
    Am J Dermatopathol. 2023;45:81-85.
    PubMed         Abstract available

  3. MATA DA, Lian CG, Hafeez F
    Determining the Association Between Melanomas and Fields of Melanocytic Dysplasia.
    Am J Dermatopathol. 2023;45:90-92.
    PubMed         Abstract available

  4. CIESLAK C, Mitteldorf C, Kromer-Olbrisch T, Kempf W, et al
    QuPath Analysis for CD30+ Cutaneous T-Cell Lymphoma.
    Am J Dermatopathol. 2023;45:93-98.
    PubMed         Abstract available

  5. DONATI M, Steiner P, Kazakov DV
    BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:117-122.
    PubMed         Abstract available

  6. LEVETT K, Taylor B, Krishnan B, Ramani NS, et al
    Recurrent Neuroendocrine Primary Cutaneous Mucinous Carcinoma of the Scalp After Complete Excision.
    Am J Dermatopathol. 2023;45:123-126.
    PubMed         Abstract available

  7. REGMI A, Raouf M, Mudaliar KM, Speiser JJ, et al
    Primary Cutaneous Ewing Sarcoma of the Scalp With Metastasis to the Lung: An Unusual Manifestation During Pregnancy.
    Am J Dermatopathol. 2023;45:127-132.
    PubMed         Abstract available

  8. HARTZELL C, Hernandez E, Arriola AGP
    A Rare Collison of Vulvar Melanoma and Extramammary Paget Disease: Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:133-136.
    PubMed        

  9. DHILLON RK, Nguyen TH, Niemann A, Karai L, et al
    Keratotic Papules on a Patient With Down Syndrome.
    Am J Dermatopathol. 2023;45:145-146.
    PubMed        

  10. LAWSON O, Patel T, Lange L
    Pyogenic Granuloma-Like Kaposi Sarcoma: Answer.
    Am J Dermatopathol. 2023;45:149-150.
    PubMed        

  11. DHILLON RK, Nguyen TH, Niemann A, Karai L, et al
    Keratotic Papules on a Patient With Down Syndrome: Challenge.
    Am J Dermatopathol. 2023;45:e9-e10.
    PubMed        


    Am J Ophthalmol

  12. LIEGL R, Schmelter V, Fuerweger C, Ehret F, et al
    Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma.
    Am J Ophthalmol. 2023 Jan 12:S0002-9394(22)00519.
    PubMed         Abstract available


    Ann Intern Med

  13. PISETSKY DS
    In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk.
    Ann Intern Med. 2023;176:JC5.
    PubMed         Abstract available

  14. MCLERNON DJ, Giardiello D, Van Calster B, Wynants L, et al
    Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models.
    Ann Intern Med. 2023;176:105-114.
    PubMed         Abstract available


    Br J Dermatol

  15. VITTRUP I, Andersen YMF, Skov L, Wu JJ, et al
    The association between atopic dermatitis, cognitive function and school performance in children and young adults.
    Br J Dermatol. 2022 Nov 3:ljac058. doi: 10.1093.
    PubMed         Abstract available

  16. LAN J, Huang Q, Yang L, Li Y, et al
    Effects of ambient air pollution on outpatient visits for psoriasis in Wuhan, China: a time-series analysis.
    Br J Dermatol. 2022 Dec 19:ljac124. doi: 10.1093.
    PubMed         Abstract available

  17. TURNER CT, Zeglinski MR, Boivin W, Zhao H, et al
    Granzyme K contributes to endothelial microvascular damage and leakage during skin inflammation.
    Br J Dermatol. 2022 Oct 23:ljac017. doi: 10.1093.
    PubMed         Abstract available

  18. EBATA T
    Dose flexibility of oral Janus kinase inhibitors for long-term control of atopic dermatitis.
    Br J Dermatol. 2022 Jan 19:ljac082. doi: 10.1093.
    PubMed        

  19. KEZIC S, van der Molen HF
    Occupational skin cancer: measurements of ultraviolet radiation exposure bring knowledge for prevention.
    Br J Dermatol. 2022 Dec 14:ljac127. doi: 10.1093.
    PubMed        

  20. CICHY J
    Compartmentalized response of the human epidermis to staphylococci.
    Br J Dermatol. 2022 Dec 21:ljac125. doi: 10.1093.
    PubMed        

  21. MAUL JT, Frohlich F, Maul LV, Stunnenberg R, et al
    Access to psoriasis treatment in Brazil and Chile: A cross-sectional multi-centre ;Global Healthcare Study on Psoriasis.
    Br J Dermatol. 2023 Jan 19:ljac128. doi: 10.1093.
    PubMed         Abstract available

  22. PADOVESE V, Fuller LC, Griffiths CEM, Maurer T, et al
    Migrant skin health - Perspectives from the Migrant Health Summit, Malta, 2022.
    Br J Dermatol. 2023 Jan 19:ljad001. doi: 10.1093.
    PubMed        

  23. ARDERN-JONES MR, Buchanan EE, Njungu S, O'Driscoll D, et al
    Successful Dose Reduction of Dupilumab in Atopic Dermatitis.
    Br J Dermatol. 2023 Jan 20:ljad011. doi: 10.1093.
    PubMed        


    Cancer

  24. ATKINS SLP, Zimmer AS
    Neurologic complications of breast cancer.
    Cancer. 2022 Dec 20. doi: 10.1002/cncr.34518.
    PubMed         Abstract available

  25. ALLEN PB, McCook-Veal AA, Switchenko JM, Paulino DM, et al
    Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
    Cancer. 2023;129:541-550.
    PubMed         Abstract available

  26. WIN TS, Tsao H
    Keratinocytic skin cancers-Update on the molecular biology.
    Cancer. 2023 Jan 16. doi: 10.1002/cncr.34635.
    PubMed         Abstract available


    Cancer Res

  27. WANG F, Moon W, Letsou W, Sapkota Y, et al
    Genome-wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk.
    Cancer Res. 2022 Nov 10. pii: 710536. doi: 10.1158/0008-5472.CAN-22-1888.
    PubMed         Abstract available

  28. LLANO E, Todeschini AL, Felipe-Medina N, Corte-Torres MD, et al
    The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Cancer Res. 2023;83:239-250.
    PubMed         Abstract available

  29. STEVENS LE, Peluffo G, Qiu X, Temko D, et al
    JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states.
    Cancer Res. 2022 Nov 21:CAN-22-0423. doi: 10.1158/0008-5472.CAN-22-0423.
    PubMed         Abstract available


    Clin Exp Dermatol

  30. BALESTRI R, Magnano M, Pedrolli A, Girardelli CR, et al
    Treatment of purely cutaneous Rosai Dorfman disease with topical rapamycin.
    Clin Exp Dermatol. 2023 Jan 17:llad018. doi: 10.1093.
    PubMed        

  31. NARANG I, Smith J, Bleiker TO
    The National Institute for Health and Care Excellence recommends glucose monitoring devices for all patients with Type 1 diabetes: anticipating further increase in cutaneous reactions to these devices.
    Clin Exp Dermatol. 2022 Nov 16:llac076. doi: 10.1093.
    PubMed        


  32. Erratum to: Interleukin-18 as a severity marker and novel potential therapeutic target for epidermolytic ichthyosis.
    Clin Exp Dermatol. 2023 Jan 19:llad006. doi: 10.1093.
    PubMed        

  33. ANSAI O, Miyauchi T, Hayashi R, Katsumi T, et al
    Interleukin-18 as a severity marker and novel potential therapeutic target for epidermolytic ichthyosis.
    Clin Exp Dermatol. 2022 Nov 11:llac069. doi: 10.1093.
    PubMed         Abstract available

  34. MUSTARI AP, Parkhi M, Vinay K
    Multiple waxy papules in a middle-aged woman.
    Clin Exp Dermatol. 2023 Jan 19:llad027. doi: 10.1093.
    PubMed        

  35. HERBERT S, Haughton R, Nava J, Ji-Xu A, et al
    A review of topical probiotic therapy for atopic dermatitis.
    Clin Exp Dermatol. 2023 Jan 20:llac138. doi: 10.1093.
    PubMed         Abstract available

  36. TRIWATCHARIKORN J, Pholmoo N, Ratanasutiranont N, Rerknimitr P, et al
    Skin testing might have a diagnostic role in immune complex-mediated hypersensitivity reactions.
    Clin Exp Dermatol. 2023;48:27-30.
    PubMed         Abstract available

  37. FAN R, Leasure AC, Damsky W, Cohen JM, et al
    Migraine among adults with atopic dermatitis: a cross-sectional study in the All of Us research programme.
    Clin Exp Dermatol. 2023;48:24-26.
    PubMed         Abstract available

  38. SHEPPARD R, Gan WK, Onambele-Pearson GL, Young HS, et al
    Developing an aerobic exercise intervention for patients with psoriasis to support lifestyle behaviour change and improve health outcomes.
    Clin Exp Dermatol. 2023;48:5-11.
    PubMed         Abstract available

  39. PANJIYAR R, Mahajan R, Bhatia A, Narang T, et al
    Cross-sectional study to estimate the prevalence and risk factors of nonalcoholic fatty liver disease in children and adolescents with psoriasis.
    Clin Exp Dermatol. 2023;48:12-19.
    PubMed         Abstract available

  40. HASSAN IH, Cakirli YA, Scharrer K, Willey A, et al
    Multiple painful skin papules, uterine leiomyomas and hysterectomy.
    Clin Exp Dermatol. 2023;48:54-56.
    PubMed        

  41. MUSTARI AP, Kittu M, Reddy P, Bhandari A, et al
    Rare cutaneous association of tuberous sclerosis.
    Clin Exp Dermatol. 2023;48:64-66.
    PubMed        

  42. DARUISH M, Papa S, L C Geh J, M Stefanato C, et al
    Papulonodular pigmented lesions in a patient with Stage IV malignant melanoma.
    Clin Exp Dermatol. 2023;48:57-59.
    PubMed        


    Cutis

  43. VU M, Gillooly Z, Becker E, Osswald S, et al
    Acquired Acrodermatitis Enteropathica in an Infant.
    Cutis. 2022;110:281-283.
    PubMed         Abstract available

  44. MARTIN TM, Tapia-Centola B, Loo DS
    Yellow Nodule on the Scalp.
    Cutis. 2022;110:E18-E19.
    PubMed        

  45. DUMAN DD, Durmaz EO
    Itchy Red-Brown Spots on a Child.
    Cutis. 2022;110:248-258.
    PubMed        

  46. YOUSEFIAN F, Espinoza L, Nutt TJ
    Painful and Pruritic Eruptions on the Entire Body.
    Cutis. 2022;110:E5-E6.
    PubMed        

  47. GRESHAM LN, Kimmis BD, Rajpara A
    Diffuse Papular Eruption With Erosions and Ulcerations.
    Cutis. 2022;110:E15-E17.
    PubMed        

  48. VISCONTI MJ, Richardson A, LaFond AA
    Dupilumab as a Therapeutic Approach in Alopecia Universalis.
    Cutis. 2022;110:E7-E8.
    PubMed        

  49. ELSAIE ML
    Update on Tinea Capitis Diagnosis and Treatment.
    Cutis. 2022;110:238-240.
    PubMed        


    Int J Dermatol

  50. KAM S, Hwang BJ, Parker ER
    The impact of climate change on atopic dermatitis and mental health comorbidities: a review of the literature and examination of intersectionality.
    Int J Dermatol. 2023 Jan 14. doi: 10.1111/ijd.16557.
    PubMed         Abstract available

  51. AVILES-IZQUIERDO JA, Garcia-Piqueras P, Ciudad-Blanco C, Lozano-Masdemont B, et al
    Do not PASS any melanoma without diagnosis: a new simplified dermoscopic algorithm.
    Int J Dermatol. 2023 Jan 20. doi: 10.1111/ijd.16573.
    PubMed         Abstract available

  52. PODDER I, Jaiswal S, Das A
    Dietary strategies for chronic spontaneous urticaria: an evidence-based review.
    Int J Dermatol. 2023;62:143-153.
    PubMed         Abstract available

  53. SOSH D, Hyde J, Dulmage B
    The efficacy of 308-nm excimer laser in the treatment of mycosis fungoides.
    Int J Dermatol. 2023;62:e92-e93.
    PubMed        

  54. ZIMMERMAN L, Trodello C, Bain M
    Isolated congenital nevoid linear hypertrichosis in an infant: a case report.
    Int J Dermatol. 2023;62:e94-e95.
    PubMed        

  55. SLUDER IT, Stokes MM, Sayed CJ, Holahan HM, et al
    Readability of online materials for hidradenitis suppurativa.
    Int J Dermatol. 2023;62:e75-e77.
    PubMed        

  56. BARTLEY BR, Simonette RA, Rady PL, Doan HQ, et al
    Molecular evidence for selinexor as a treatment for Merkel cell polyomavirus (MCPyV)-positive Merkel cell carcinoma.
    Int J Dermatol. 2023;62:e68-e70.
    PubMed        

  57. AYEN-RODRIGUEZ A, Llamas-Molina JM, Galvez-Moreno M, Ruiz-Villaverde R, et al
    Cold urticarial vasculitis successfully treated with omalizumab.
    Int J Dermatol. 2023;62:e77-e78.
    PubMed        

  58. ZHOU AE, Hoegler KM, Khachemoune A
    Desperate need for consensus guidelines and recommendations upon encountering perineural inflammation in keratinocyte carcinomas.
    Int J Dermatol. 2023;62:e96-e97.
    PubMed        

  59. SHAH SD, Nikam BP, Ankad BS, Anusha HL, et al
    Pseudolymphomatous folliculitis after hair transplantation: dermoscopic view of a rare entity.
    Int J Dermatol. 2023;62:e81-e83.
    PubMed        

  60. MIIDA H
    Association between clinical appearance and histological findings in pilomatricomas.
    Int J Dermatol. 2023;62:e100-e102.
    PubMed        

  61. SONS JS, Chateau AV
    A case of verrucous carcinoma arising from a burn scar on the scalp of an HIV-positive patient.
    Int J Dermatol. 2022 Nov 23. doi: 10.1111/ijd.16518.
    PubMed        

  62. OCHOA-RAMIREZ LA, Diaz-Camacho SP, Mellado-Corrales SN, Munoz-Estrada VF, et al
    Analysis of the heat shock protein 70 (HSP70) genetic variants in nonsegmental vitiligo patients.
    Int J Dermatol. 2023;62:225-230.
    PubMed         Abstract available

  63. KUTLU O, Demircan YT, Yildiz K, Kalkan G, et al
    The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study.
    Int J Dermatol. 2023;62:202-211.
    PubMed         Abstract available

  64. YOUNG PC, Mahajan C, Shapiro J, Tosti A, et al
    Digital health platforms expand access and improve care for male androgenetic alopecia.
    Int J Dermatol. 2023;62:217-220.
    PubMed         Abstract available

  65. HERRERO-RUIZ SP, Garrido-Rios AA, Romero-Mate A, Khedaoui R, et al
    Facial hyperpigmentation with singular dermoscopic findings.
    Int J Dermatol. 2023;62:197-198.
    PubMed        

  66. DE FREITAS ACP, Rigon RB, Bagatin E, Leonardi GR, et al
    Perspectives of topical formulations for melasma.
    Int J Dermatol. 2023;62:260-268.
    PubMed         Abstract available

  67. ATZORI L, Ferreli C, Agosta D, Mou M, et al
    Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease.
    Int J Dermatol. 2023;62:246-249.
    PubMed        

  68. JOHN JM, Sinclair RD
    Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review.
    Int J Dermatol. 2023;62:257-259.
    PubMed         Abstract available

  69. ROMAGNUOLO M, Alberti Violetti S, Riva D, Barberi F, et al
    Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor palbociclib.
    Int J Dermatol. 2023;62:e98-e100.
    PubMed        

  70. GORI N, Cappilli S, Di Stefani A, Tassone F, et al
    Assessment of alopecia areata universalis successfully treated with upadacitinib.
    Int J Dermatol. 2023;62:e61-e63.
    PubMed        

  71. RUGGIERO A, Villani A, Fabbrocini G, Martora F, et al
    Reply to: "Usage and perceptions of teledermatology in 2021: a survey of dermatologists" by Ahmad et al.
    Int J Dermatol. 2023;62:e80-e81.
    PubMed        

  72. LAURO W, Picone V, Abategiovanni L, Vastarella M, et al
    A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation.
    Int J Dermatol. 2023;62:e70-e72.
    PubMed        


    J Cutan Pathol

  73. LIN EM, Singer H, Telang GH, Chau T, et al
    Cutaneous Sporothrix globosa infection mimicking cryptococcosis in a patient with history of kidney transplant.
    J Cutan Pathol. 2023 Jan 20. doi: 10.1111/cup.14396.
    PubMed         Abstract available

  74. BELZER A, Becerra C, Clune J, Malik M, et al
    Histopathologic features and immunohistochemistry findings to assist the dermatopathologist in differentiating melanocytic matrical carcinoma from melanoma.
    J Cutan Pathol. 2023 Jan 16. doi: 10.1111/cup.14376.
    PubMed        


    J Dermatol

  75. WANG WM, Jin HZ
    Biologics in pediatric psoriasis.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16702.
    PubMed         Abstract available

  76. MURAKAMI T, Aozasa N, Fukano H, Miyamoto Y, et al
    Successful treatment of cutaneous Mycobacterium chelonae infection by switching from levofloxacin to sitafloxacin.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16720.
    PubMed        

  77. KAMIYA S, Koizumi H, Suzuki Y, Imai S, et al
    Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16726.
    PubMed        


    J Invest Dermatol

  78. LUO L, Pasquali L, Srivastava A, Freisenhausen JC, et al
    The long non-coding RNA LINC00958 is induced in psoriasis epidermis and modulates epidermal proliferation.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(22)02905.
    PubMed         Abstract available

  79. PADHI A, Rekha RS, Benrejdal L, Grundeken ME, et al
    Baricitinib blocks cytokine mediated downregulation of PAD1 in human keratinocytes: a possible molecular link to the effects of JAK-inhibitors in atopic dermatitis.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(23)00001.
    PubMed        

  80. KIM RW, An Y, Zukley L, Ferrucci L, et al
    Skin Barrier Function and Cognition Among Older Adults.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(22)02897.
    PubMed        

  81. NEMETH T, Balogh L, Kaposztas E, Szilveszter KP, et al
    Neutrophil-specific Syk expression is crucial for skin disease in experimental epidermolysis bullosa acquisita.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(23)00010.
    PubMed         Abstract available

  82. DELLA BELLA C, Corra A, Mantengoli E, Galano A, et al
    Skin IL-17A and IFN-gamma production correlate with disease severity in patients with psoriasis and streptococcal infection.
    J Invest Dermatol. 2023 Jan 12:S0022-202X(22)02899.
    PubMed         Abstract available

  83. SCHMIDT AD, Miciano C, Zheng Q, Mathyer ME, et al
    Involucrin modulates vitamin D receptor activity in the epidermis.
    J Invest Dermatol. 2023 Jan 12:S0022-202X(22)02903.
    PubMed         Abstract available


    Lancet

  84. ZHOU YB
    Pseudovesicular appearance in Sweet's syndrome: important yet easily missed.
    Lancet. 2023;401:104.
    PubMed        

  85. BANARES J, Aceituno L, Jimenez A, Maynard A, et al
    Pseudovesicular appearance in Sweet's syndrome: important yet easily missed - Authors' reply.
    Lancet. 2023;401:104.
    PubMed        

  86. HURVITZ SA, Hegg R, Chung WP, Im SA, et al
    Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
    Lancet. 2022 Dec 6:S0140-6736(22)02420-5. doi: 10.1016/S0140-6736(22)02420.
    PubMed         Abstract available

  87. RASSY E, Delaloge S
    A second-generation antibody-drug conjugate to treat HER2-positive breast cancer.
    Lancet. 2022 Dec 7:S0140-6736(22)02534-X. doi: 10.1016/S0140-6736(22)02534.
    PubMed        


    N Engl J Med

  88. ROSMARIN D, Kornacki D, Ezzedine K
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply.
    N Engl J Med. 2023;388:284.
    PubMed        

  89. JANSSEN JC, Mulder EEAP, van der Veldt AAM
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
    N Engl J Med. 2023;388:283.
    PubMed        


    PLoS Genet

  90. FERRANDO L, Vingiani A, Garuti A, Vernieri C, et al
    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
    PLoS Genet. 2023;19:e1010563.
    PubMed         Abstract available


    PLoS One

  91. BOUGUETTAYA A, Gethin G, Probst S, Sixsmith J, et al
    How health literacy relates to venous leg ulcer healing: A scoping review.
    PLoS One. 2023;18:e0279368.
    PubMed         Abstract available

  92. ZHENG H, Ge C, Lin H, Zhou S, et al
    The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.
    PLoS One. 2023;18:e0280474.
    PubMed         Abstract available

  93. VANHOUDT A, Jacobs C, Caron M, Barkema HW, et al
    Broad-spectrum infrared thermography for detection of M2 digital dermatitis lesions on hind feet of standing dairy cattle.
    PLoS One. 2023;18:e0280098.
    PubMed         Abstract available

  94. FLOOD E, Krasnow A, Orbegoso C, Karantzoulis S, et al
    Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer.
    PLoS One. 2023;18:e0280259.
    PubMed         Abstract available

  95. SYED A, Adam R, Ren T, Lu J, et al
    Machine learning with textural analysis of longitudinal multiparametric MRI and molecular subtypes accurately predicts pathologic complete response in patients with invasive breast cancer.
    PLoS One. 2023;18:e0280320.
    PubMed         Abstract available

  96. CHRISTENSEN PKF, Hansen AK, Skov S, Engkilde K, et al
    Sustaining the T-cell activity in xenografted psoriasis skin.
    PLoS One. 2023;18:e0278390.
    PubMed         Abstract available

  97. ISLAM N, Bhuiyan AKMMR, Alam A, Chowdhury MK, et al
    Coping strategy among the women with metastatic breast cancer attending a palliative care unit of a tertiary care hospital of Bangladesh.
    PLoS One. 2023;18:e0278620.
    PubMed         Abstract available

  98. MALKI A, Verkerke GJ, Dekker R, Hijmans JM, et al
    Factors influencing the use of therapeutic footwear in persons with diabetes mellitus and loss of protective sensation: A focus group study.
    PLoS One. 2023;18:e0280264.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: